Complex dispersions of poloxamers and mesoporous carriers with ibrutinib
Authors:
- Igor A. DainIDIgor A. Dain
- Sergey A. ZolotovSZSergey A. Zolotov
- Natalia B. DeminaNDNatalia B. Demina
- Anna S. ZolotovaAZAnna S. Zolotova
- Grigorii A. BuzanovGBGrigorii A. Buzanov
- Vasilii M. RetivovVRVasilii M. Retivov
- Yevgenii S. PonomaryovYPYevgenii S. Ponomaryov
Open Access
Abstract
No abstract availableFunding Information
- Ministry of Education and Science of the Russian Federation (075-11-2021-070)
- National Research Council Canada
This publication has 22 references indexed in Scilit:
- Determining the Best Poloxamer Carrier for Thiocolchicoside Solid DispersionsTurkish Journal of Pharmaceutical Sciences, 2020
- Microcrystalline cellulose as an effective crystal growth inhibitor for the ternary Ibrutinib formulationCarbohydrate Polymers, 2020
- Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamideInternational Journal of Pharmaceutics, 2019
- Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole BioperformanceJournal of Pharmaceutical Sciences, 2018
- Investigating the Effects of Loading Factors on the In Vitro Pharmaceutical Performance of Mesoporous Materials as Drug Carriers for IbuprofenMaterials, 2017
- BCS class IV drugs: Highly notorious candidates for formulation developmentJournal of Controlled Release, 2017
- Mesoporous Silica as a Carrier for Amorphous Solid DispersionBritish Journal of Pharmaceutical Research, 2017
- Mesoporous silica formulation strategies for drug dissolution enhancement: a reviewExpert Opinion on Drug Delivery, 2015
- Preformulation Studies on Solid Self-Emulsifying Systems in Powder Form Containing Magnesium Aluminometasilicate as Porous CarrierAAPS PharmSciTech, 2014
- Liquisolid systems and aspects influencing their research and developmentActa Pharmaceutica, 2013